Stroke is the second most common single cause of death worldwide, with over five million deaths per year globally. So far, conventional therapy has failed to restore neurological function poststroke. Neurorestorative strategy has provided therapeutic benefit for the treatment of stroke. This review outlines the clinical advances, in which cell-based neurorestorative strategies offer the broadest range of potential treatments for stroke.
No takes yet. Share an insight, caveat, or question.
Qiao et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: